SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD. Funds and ETFs Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
Equities
1349
CNE1000000W4
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.16 HKD | -0.92% |
|
+2.37% | -15.29% |
ETFs positioned on Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.32% | - |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-18
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.29% | 849M | |
| +12.26% | 9B | |
| -12.75% | 4.96B | |
| +42.38% | 4.47B | |
| +5.23% | 3.9B | |
| +20.51% | 2.45B | |
| -19.05% | 2.41B | |
| -28.72% | 2.23B | |
| +11.13% | 2.02B | |
| +3.94% | 1.65B |
- Stock Market
- Equities
- 1349 Stock
- Funds and ETFs Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
